[TARS] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[TARS] Tarsus Pharmaceuticals, Inc.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -24.58%
YoY- -73.91%
Quarter Report
TARS's Result
TARS's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
Revenue 48,118 1,871 0 1,240 0 0 -
PBT -23,420 -40,935 -22,516 -16,038 -10,137 -681 102.74%
Tax 0 -1,787 -5 -341 1 48 -
NP -23,420 -39,148 -22,511 -15,697 -10,138 -681 102.74%
Tax Rate - - - - - - -
Total Cost 71,538 41,019 22,511 16,937 10,138 681 153.41%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
NP Margin -48.67 -2,092.36 0.00 -1,265.89 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 CAGR
EPS -0.61 -1.28 -0.84 -0.76 -0.54 -0.06 58.93%
EPS Diluted -0.61 -1.28 -0.84 -0.76 -0.54 -0.06 58.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.